Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy
Cardiac allograft vasculopathy (CAV)—mediated by a heterogeneous myriad of immune and
non-immune factors, which contribute to the progressive and diffuse thickening of the arterial …
non-immune factors, which contribute to the progressive and diffuse thickening of the arterial …
Vanadium Pentaoksida (V2O5): Termodinamika Molecular dan Interaksi Ion dalam Larutan
M Shafitri, R Zainul - 2019 - osf.io
Vanadium Pentaoksida merupakan senyawa dengan rumus V2O5. Vanadium Pentaoksida
bewarna kuning orange dan ketika membeku membentuk kristal seperti jarum. Vanadium …
bewarna kuning orange dan ketika membeku membentuk kristal seperti jarum. Vanadium …
Effects of Rapamycin on the Expression of Redox Enzymes in Aortic Vascular Smooth Muscle Cells from Marfan Syndrome Mice
Activation of the mechanistic target of rapamycin (mTOR) pathway has been implicated in an
increasing number of diseases, including Marfan syndrome (MFS), an inherited connective …
increasing number of diseases, including Marfan syndrome (MFS), an inherited connective …
AAV-mediated expression of AP-1-neutralizing RNA decoy oligonucleotides attenuates transplant vasculopathy in mouse aortic allografts
A Remes, M Franz, F Mohr, A Weber, K Rapti… - … Therapy-Methods & …, 2019 - cell.com
Transplant vasculopathy (TV), characterized by obstructive lesions in affected vessels,
represents one of the long-term complications of cardiac transplantation. Activation of the …
represents one of the long-term complications of cardiac transplantation. Activation of the …
Gentherapie der Transplantatvaskulopathie
R Arif, K Kallenbach, OJ Müller, AH Wagner - Zeitschrift für Herz-, Thorax …, 2022 - Springer
Das Forschungsprojekt befasste sich mit der gentherapeutischen Behandlung der
Transplantatvaskulopathie (TVP). Unter Verwendung des heterotopen …
Transplantatvaskulopathie (TVP). Unter Verwendung des heterotopen …